Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Alonso-Pérez V"'
Autor:
Alonso-Pérez V; Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Centro de Investigación del Cáncer (CIC), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain., Hernández V; Biological Clues of the Invasive and Metastatic Phenotype Group, Molecular Oncology Department, Bellvitge Biomedical Research Institute (IDIBELL), E-08907 L'Hospitalet de Llobregat, Barcelona, Spain., Calzado MA; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), E-14004 Córdoba, Spain; Departamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, E-14004 Córdoba, Spain; Hospital Universitario Reina Sofía, E-14004 Córdoba, Spain., Vicente-Blázquez A; Laboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas Margarita Salas, CSIC, C/ Ramiro de Maeztu 9, E-28040 Madrid, Spain; Department of Biology, American University, Washington, DC 20016, USA., Gajate C; Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Centro de Investigación del Cáncer (CIC), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain; Laboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas Margarita Salas, CSIC, C/ Ramiro de Maeztu 9, E-28040 Madrid, Spain., Soler-Torronteras R; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), E-14004 Córdoba, Spain; Departamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, E-14004 Córdoba, Spain; Hospital Universitario Reina Sofía, E-14004 Córdoba, Spain., DeCicco-Skinner K; Department of Biology, American University, Washington, DC 20016, USA., Sierra A; Biological Clues of the Invasive and Metastatic Phenotype Group, Molecular Oncology Department, Bellvitge Biomedical Research Institute (IDIBELL), E-08907 L'Hospitalet de Llobregat, Barcelona, Spain; Laboratory of Experimental Oncological Neurosurgery, Neurosurgery Service, Hospital Clinic de Barcelona-FCRB, E-08036 Barcelona, Spain; Department of Medicine and Life Sciences (MELIS), Faculty of Health and Live Sciences, Universitat Pompeu Fabra, E-08036 Barcelona, Spain., Mollinedo F; Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Centro de Investigación del Cáncer (CIC), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain; Laboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas Margarita Salas, CSIC, C/ Ramiro de Maeztu 9, E-28040 Madrid, Spain. Electronic address: fmollin@cib.csic.es.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Feb; Vol. 171, pp. 116149. Date of Electronic Publication: 2024 Jan 24.
Autor:
Quijada-Álamo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA., Rodríguez-Vicente AE; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pérez-Carretero C; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rodríguez-Sánchez A; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Martín-Izquierdo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Alonso-Pérez V; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., García-Tuñón I; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Bastida JM; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Vidal-Manceñido MJ; Department of Hematology, Hospital Virgen Blanca, León, Spain., Galende J; Department of Hematology, Hospital del Bierzo, Ponferrada, Spain., Aguilar C; Department of Hematology, Hospital Santa Bárbara, Soria, Spain., Queizán JA; Department of Hematology, Hospital General de Segovia, Segovia, Spain., González-Gascón Y Marín I; Department of Hematology, Hospital Universitario Infanta Leonor. Universidad Complutense, Madrid, Spain., Hernández-Rivas JÁ; Department of Hematology, Hospital Universitario Infanta Leonor. Universidad Complutense, Madrid, Spain., Benito R; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Ordóñez JL; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Rivas JM; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain. jmhr@usal.es.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain. jmhr@usal.es.; Department of Medicine, University of Salamanca, Salamanca, Spain. jmhr@usal.es.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2021 Jul 09; Vol. 11 (7), pp. 127. Date of Electronic Publication: 2021 Jul 09.
Publikováno v:
In International Journal of Pharmaceutics 2005 294(1):217-232
Autor:
Quijada-Álamo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA., Alonso-Pérez V; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rodríguez-Vicente AE; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., García-Tuñón I; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Martín-Izquierdo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez JM; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Herrero AB; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Bastida JM; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., San Segundo L; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Gruber M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.; CeMM Research Center for Molecular Medicine, Vienna, Austria.; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., García JL; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA., Ten Hacken E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA., Benito R; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Ordóñez JL; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain. jlog@usal.es.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain. jlog@usal.es., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA. cwu@partners.org.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. cwu@partners.org., Hernández-Rivas JM; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain. jmhr@usal.es.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain. jmhr@usal.es.; Department of Medicine, University of Salamanca, Salamanca, Spain. jmhr@usal.es.
Publikováno v:
Leukemia [Leukemia] 2020 Jun; Vol. 34 (6), pp. 1599-1612. Date of Electronic Publication: 2020 Jan 23.
Autor:
Vuelta E; Unidad de Diagnóstico Molecular y Celular del Cáncer, Instituto Biología Molecular y Celular del Cáncer (USAL/CSIC), Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; Servicio de Transgénesis, NUCLEUS, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Ordoñez JL; Unidad de Diagnóstico Molecular y Celular del Cáncer, Instituto Biología Molecular y Celular del Cáncer (USAL/CSIC), Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Alonso-Pérez V; Unidad de Diagnóstico Molecular y Celular del Cáncer, Instituto Biología Molecular y Celular del Cáncer (USAL/CSIC), Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Méndez L; Servicio de Transgénesis, NUCLEUS, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Hernández-Carabias P; Servicio de Transgénesis, NUCLEUS, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Saldaña R; Servicio de Hematología, Hospital de Jerez, Cádiz, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Sevilla J; Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Sebastián E; Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Muntión S; Unidad de Diagnóstico Molecular y Celular del Cáncer, Instituto Biología Molecular y Celular del Cáncer (USAL/CSIC), Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; RETIC TerCel y CIBERONC, ISCIII, Madrid, Spain; and Hospital Universitario de Salamanca, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Sánchez-Guijo F; Unidad de Diagnóstico Molecular y Celular del Cáncer, Instituto Biología Molecular y Celular del Cáncer (USAL/CSIC), Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; RETIC TerCel y CIBERONC, ISCIII, Madrid, Spain; and Hospital Universitario de Salamanca, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Hernández-Rivas JM; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., García-Tuñón I; Unidad de Diagnóstico Molecular y Celular del Cáncer, Instituto Biología Molecular y Celular del Cáncer (USAL/CSIC), Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain., Sánchez-Martín M; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; Servicio de Transgénesis, NUCLEUS, Universidad de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain; Hospital Universitario de Salamanca, Salamanca, Spain.
Publikováno v:
The CRISPR journal [CRISPR J] 2021 Aug; Vol. 4 (4), pp. 519-535.
Autor:
Montaño A; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain., Ordoñez JL; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.; Dept of Biochemistry and Molecular Biology, University of Salamanca, Campus Unamuno s/n, 37007 Salamanca, Spain., Alonso-Pérez V; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain., Hernández-Sánchez J; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain., Santos S; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain., González T; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, 37007 Salamanca, Spain., Benito R; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain., García-Tuñón I; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain., Hernández-Rivas JM; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.; Department of Medicine, Universidad de Salamanca and CIBERONC, 37007 Salamanca, Spain.
Publikováno v:
Cells [Cells] 2020 Jan 15; Vol. 9 (1). Date of Electronic Publication: 2020 Jan 15.
Autor:
Zhuang, Shiwei1 (AUTHOR) 13604414589@163.com, Liu, Zhimei1 (AUTHOR), Wu, Jinyao1 (AUTHOR), Yao, Yudan1 (AUTHOR), Li, Zongyang1 (AUTHOR), Shen, Yanxiang1 (AUTHOR), Yu, Bin1 (AUTHOR), Wu, Donglu1 (AUTHOR) wudl1020@163.com
Publikováno v:
Pharmaceuticals (14248247). Jun2024, Vol. 17 Issue 6, p664. 15p.
Autor:
García-Tuñón I; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Alonso-Pérez V; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Vuelta E; Servicio de Transgénesis, Nucleus, Universidad de Salamanca, Salamanca, Spain., Pérez-Ramos S; Servicio de Transgénesis, Nucleus, Universidad de Salamanca, Salamanca, Spain., Herrero M; Servicio de Transgénesis, Nucleus, Universidad de Salamanca, Salamanca, Spain., Méndez L; Servicio de Transgénesis, Nucleus, Universidad de Salamanca, Salamanca, Spain., Hernández-Sánchez JM; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Martín-Izquierdo M; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Saldaña R; Servicio de Hematología, Hospital de Especialidades de Jerez, Zacatecas, Spain., Sevilla J; Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Sánchez-Guijo F; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Hernández-Rivas JM; Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Sánchez-Martín M; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Servicio de Transgénesis, Nucleus, Universidad de Salamanca, Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.
Publikováno v:
PloS one [PLoS One] 2019 May 09; Vol. 14 (5), pp. e0216674. Date of Electronic Publication: 2019 May 09 (Print Publication: 2019).
Autor:
Wu, Andrew1,2 (AUTHOR) awu@bccrc.ca, Liu, Xiaohu1,2 (AUTHOR) wliu@virogin.com, Fruhstorfer, Clark1 (AUTHOR), Jiang, Xiaoyan1,2,3 (AUTHOR) xjiang@bccrc.ca
Publikováno v:
International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 6, p3307. 23p.
Autor:
Ilahibaks, Nazma F.1 (AUTHOR), Kluiver, Thomas A.2 (AUTHOR), de Jong, Olivier G.3 (AUTHOR), de Jager, Saskia C. A.1 (AUTHOR), Schiffelers, Raymond M.4 (AUTHOR), Vader, Pieter1,4 (AUTHOR), Peng, Weng Chuan2 (AUTHOR), Lei, Zhiyong1,4 (AUTHOR), Sluijter, Joost P. G.1,5 (AUTHOR) j.sluijter@umcutrecht.nl
Publikováno v:
Journal of Extracellular Vesicles. Jan2024, Vol. 13 Issue 1, p1-13. 13p.